The differential gene expression analyses were performed using The Cancer Genome Atlas (TCGA) database and suggested that the IGF2BP3 mRNA levels were elevated in most human cancers compared to the corresponding normal tissues based on the pan‐cancer view of IGF2BP3 in human cancers, including head and neck cancer (http://gepia.cancer‐pku.cn/). This evidence concerns the gene IGF2BP3 and head and neck cancer.